SLC8A3

mass-spec protein & survival
Survivalmass-specKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, SLC8A3 mass-spec protein is linked to patient survival in 1 of 34 cancer types, making it a survival-associated SLC8A3 data layer compared with 22 for mass-spec protein and 7 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher SLC8A3 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated SLC8A3 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC are the cancer types where SLC8A3 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
UCECDFSTertileIII,IV1.0000.640.0408view →
Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

SLC8A3–UCEC (DFS)

Kaplan–Meier survival curve for SLC8A3 mass-spec protein-high vs -low samples in UCEC.

Open the UCEC breakdown →

Exploration